Related Experiment Video
Updated: Aug 15, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Synthesis of thromboxane B2 metabolites
Prostaglandins
|July 1, 1978
Summary
Researchers synthesized novel thromboxane B2 derivatives, including 11-dehydro and 15-dehydro forms. These synthesized compounds are potential thromboxane metabolites, aiding further research into their biological roles.
Area of Science:
- Organic Chemistry
- Biochemistry
- Pharmacology
Background:
- Thromboxanes are potent lipid mediators involved in platelet aggregation and vasoconstriction.
- Understanding thromboxane metabolism is crucial for developing therapies for cardiovascular diseases.
- Previous studies have identified various thromboxane metabolites in biological systems.
Purpose of the Study:
- To synthesize specific dehydro and dinor derivatives of thromboxane B2 methyl ester.
- To provide researchers with novel compounds for studying thromboxane metabolism.
- To facilitate the identification and characterization of thromboxane metabolites.
Main Methods:
- Chemical synthesis of 11-dehydrothromboxane B2 methyl ester (II).
- Chemical synthesis of 15-dehydrothromboxane B2 methyl ester (III).
- Chemical synthesis of 15-dehydro-13, 14-dihydrothromboxane B2 (XII).
- Chemical synthesis of 2,3-dinorthromboxane B2 methyl ester (XV).
Main Results:
- Successful synthesis of four key thromboxane B2 derivatives.
- Characterization of the synthesized compounds (details not provided in abstract).
- Availability of these compounds for further biological investigation.
Conclusions:
- The synthesized compounds represent important analogs of known thromboxane metabolites.
- These novel compounds can serve as valuable tools for elucidating thromboxane metabolic pathways.
- Further research is warranted to explore the biological activities and significance of these synthesized thromboxane derivatives.
Related Concept Videos
02:45E2 Reaction: Kinetics and Mechanism
SN2 substitutions and E2 eliminations of alkyl halides proceed via a concerted pathway. While the nucleophile attacks the alpha carbon in SN2 reactions, it functions as a strong base and abstracts a beta hydrogen in the E2 mechanism. The rate-limiting transition state in E2 elimination reactions is characterized by partially broken carbon–hydrogen and carbon–halogen bonds and a partially formed pi bond between the alpha and beta carbons. The beta hydrogen and halide are eliminated...
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...